Korro bio, inc.KRRO.US Overview

US StockHealthcare

(No presentation for KRRO)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

KRRO Overall Performance

KRRO AI Analysis & Strategy

KRRO Recent Performance

1.65%

Korro bio, inc.

0.81%

Avg of Sector

-1.14%

S&P500

KRRO PowerScanner

KRRO Key Information

KRRO Valuation Metrics

KRRO Earnings Table

KRRO Profile

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.